The Basis of What We Do
Chronic wound is a top healthcare problem in the 21st century with its number exceeding those with breast cancer, colon cancer, lung cancer and leukaemia combined. Its burden to healthcare cost is approximately US$20 billion and US$6.6 billion in United States and United Kingdom, respectively. This is in part fuelled by the increase in diabetes due to modern lifestyle, rising geriatric population and growing number of road accidents and trauma injuries.
Both global wound care and stem cell therapeutics markets are projected to be on an increasing trajectory growth in the next 5 to 7 years. Asia Pacific is expected to grow at a high pace in the coming years with increasing healthcare expenditure due to affluency and wider education outreach.
Depending on the severity (closed or open, depth of damage) of the wound, the healing process can occur through primary, secondary or tertiary intention that involve multiple stages with both intrinsic and extrinsic factors. Understanding the processes is the key to intervention.